109,000 Waiters: Organ Procurement Teams May Approach Families Before Death Is Declared

The U.S. organ transplant system is dismantling a strict barrier between hospital care teams and organ procurement staff. The Organ Procurement and Transplantation Network board voted Aug. 20 to modify long-standing rules that previously prohibited donation teams from speaking with families until after physicians decided to withdraw life-sustaining treatment. The new guidelines take effect Nov. 18 and permit discussions about organ donation once end-of-life conversations begin with the patient’s agent.

The revision aims to reduce coordination errors and increase donation rates following circulatory death, which now accounts for approximately half of all organ donations. Dr. Raymond Lynch, director of transplantation at the federal Health Resources & Services Administration, stated that maintaining a rigid separation without assessing the context creates a false sense of security. Lynch noted that past incidents, including patients being transported to operating rooms while still alive, drove the need for better communication between procurement organizations and healthcare teams.

Under the new policy, procurement teams can engage with families earlier to ensure retrieval is not delayed beyond the window for viable organ preservation. Lynch argued that late arrival deprives families of the memory of their loved one’s generosity, denies patients the choice they made, and reduces options for candidates on the waiting list. More than 109,000 Americans currently await transplants, with an estimated 12 dying daily due to chronic shortages.

Bioethicists warn the change may pressure grieving families. Dr. Lainie Ross of the University of Rochester described the previous rule as a vital bright line protecting patient care. Ross expressed concern that families might suspect doctors are suggesting treatment withdrawal to secure organs, stating that she wants to know the team is focused solely on the patient’s well-being until death is imminent.

Dr. Claire Morgan, a transplant surgeon on the network’s Patient Affairs Committee, acknowledged the benefit of transplants but cautioned against interfering with the grieving process. She emphasized that families need time to make decisions when it is correct for them. Lois Shepherd, a law and bioethics professor at the University of Virginia who opposed the change during its development, described the move as part of a pattern of blurring lines and weakening patient safeguards.

The Association of Organ Procurement Organizations supported the update in public comments. The group stated that families must understand how donor evaluation affects the timing of life support withdrawal. President Allison Erickson added in a written statement that donor families deserve full transparency regarding the end-of-life and donation processes to maintain public trust.